Evidence map›Paper›PMID 33037576›Full record

ArticleTranslational stroke research2021

Correction to: Activation of Sigma-1 Receptor Enhanced Pericyte Survival Via the Interplay between Apoptosis and Autophagy: Implications for Blood-Brain Barrier Integrity in Stroke.

Yuan Zhang, Xiaotian Zhang, Qiangqiang Wei, Shuo Leng, Cai Li, Bing Han, Ying Bai, Huibin Zhang, Honghong Yao

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Translational stroke research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Endogenous FGF21 attenuates blood-brain barrier disruption in penumbra after delayed recanalization in MCAO rats through FGFR1/PI3K/Akt pathway.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Yuan Zhang *Department of Pharmacology, School of Medicine, Southeast University, Nanjing, 210009, Jiangsu, China. yuanzhang@seu.edu.cn.
Xiaotian Zhang *PerMed Biomedicine Institute, Shanghai, 201203, China.
Qiangqiang Wei *Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing, 210009, Jiangsu, China.
Shuo Leng *Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, Jiangsu, China.
Cai LiDepartment of Neurology, Rizhao Hospital of Traditional Chinese Medicine, Rizhao, 276800, Shandong, China.
Bing HanDepartment of Pharmacology, School of Medicine, Southeast University, Nanjing, 210009, Jiangsu, China.
Ying BaiDepartment of Pharmacology, School of Medicine, Southeast University, Nanjing, 210009, Jiangsu, China.
Huibin ZhangCenter of Drug Discovery, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, Jiangsu, China. zhanghb80@cpu.edu.cn.
Honghong YaoDepartment of Pharmacology, School of Medicine, Southeast University, Nanjing, 210009, Jiangsu, China. yaohh@seu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33037576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.